A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction

Experimental and Clinical Cardiology

Volumn 15, Issue 2, 2010, Pages

  Mamas, Mamas A ^a,b   Neyses, Ludwig ^a,b   Fath Ordoubadi, Farzin ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Insulin; Meta analysis; Myocardial infarction

Indexed keywords

GLUCOSE; INSULIN; PLACEBO; POTASSIUM;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77954296979     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sodi-Pallares D, Testelli MR, Fishleder BL, et al. Effects of an intravenous infusion of potassium-glucose-insulin solution on electrocardiographic signs of myocardial infarction: A preliminary clinical report. Am J Cardiol 1962;9:166-81.
2. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002;112:305-11.
3. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
4. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999;99:578-8.
5. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
6. Van der Horst IC, Zijlstra F, van't Hof AWJ, et al; Zwolle Infarct Study Group. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: A randomized trial. J Am Coll Cardiol 2003;42:784-91.
7. Timmer JR, Svilaas T, Ottervanger JP, et al. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: The Glucose-Insulin-Potassium study II. J Am Coll Cardiol 2006;47:1730-1.
8. Mehta SR, Yusuf S, Diaz R, et al; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomised controlled trial. JAMA 2005;293:437-46.
9. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999;13:191-200.
10. Díaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 2007;298:2399-405.
11. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell, 1987.
12. Bailey NTJ. Mathematics, Statistics and Systems for Health. New York: Wiley, 1997.
13. Malmberg K, Ryden L, Wedel H, et al; DIGAMI-2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005;26:650-61.
14. Cheung NW, Wong VW, Mclean M. The hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study. A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-70.
15. Pache J, Kastrati A, Mehilli J, et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J 2004;148:1-6.
16. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998;98:2227-34.
17. Mittra B. Potassium, glucose, and insulin in treatment of myocardial infarction. Lancet 1965;2:607-9.
18. Medical Research Council Working Party on the Treatment of Myocardial Infarction. Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet 1968;2:1355-60.
19. Pilcher J, Etishamudin M, Exon P, et al. Potassium, glucose and insulin in myocardial infarction. Lancet 1967;1:1109.
20. Pentecost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet 1968;1:946-8.
21. Hjermann I. A controlled study of per oral glucose, insulin and potassium treatment in myocardial infarction. Acta Med Scand 1971;190:213-8.
22. Heng MK, Norris RM, Singh BN, et al. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J 1977;39:748-57.
23. Stanley AWH, Prather JW. Glucose-insulin-potassium, patient mortality and the acute myocardial infarction: Results from a prospective randomized study. Circulation 1978;57(Suppl II):II-62. (Abst)
24. Rogers WJ, McDaniel HG, Mantle JA, et al. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction: Effects of hemodynamics, short and long-term survival. J Am Coll Cardiol 1983;1:628.
25. Satler LF, Green CE, Kent KM, et al. Metabolic support during coronary reperfusion. Am Heart J 1987;114:54-8.
26. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: Implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
27. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: Results from the CARDINAL study. Eur Heart J 2006;27:1289-97.
28. Stanley AW, Moraski RE, Russell RO, et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilisation in stable coronary artery disease: Studies on myocardial carbohydrates, lipid and oxygen arterial coronary sinus differences in patients with coronary artery disease. Am J Cardiol 1975;36:929-37.
29. Apstein CS, Opie LH. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 2005;26:956-9.
30. Wallhaus TR, Taylor M, DeGrado H, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 2000;103:2441-6.
31. de Leiris J, Opie LH, Lubbe WF. Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction. Nature 1975;253:746-7.
32. Opie LH, Bruyneel K, Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation 1975;52:49-57.
33. Eberli FR, Weinberg EO, Grice WN, et al. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991;68:466-81.
34. Yazici M, Demircan S, Durna K, et al. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization. Am J Cardiol 2005;96:1517-20. (Pubitemid 41690171)